PIVOTAL, a global mid-sized Contract Research Organization (CRO) dedicated to advancing clinical research across multiple therapeutic areas, has been shortlisted as a finalist in the “Best Contract Research Organization Full-Services Providers” category at the prestigious 2025 Scrip Awards.
In its 21st edition, the Scrip Awards celebrate outstanding achievements in the biopharmaceutical industry, recognizing innovation, collaboration, and contributions to improving human health worldwide.
“Being shortlisted among the best CROs globally is an incredible honor that reflects the passion and excellence of our entire team,” said Lidia Farr, SVP Corporate Development of PIVOTAL. “This recognition reaffirms our commitment to driving innovation and delivering the highest quality in every clinical program we support.”
The “Best CRO” category highlights the essential role organizations like PIVOTAL play in accelerating drug development through comprehensive, technology-driven clinical services. Over the summer, a panel of 12 respected judges reviewed a record number of entries to produce a highly competitive shortlist. All submissions were evaluated by an independent group of industry veterans, including former FDA officials, biotech venture capitalists, and pharma strategists.
Winners will be announced on the 11th of December 2025 at the London Hilton Park Lane during the annual gala event attended by more than 400 industry leaders.
About Scrip Awards
The Scrip Awards are held annually in London, recognizing achievements across the entire drug development lifecycle. Widely regarded as one of the most prestigious honors in global biopharma, the event brings together more than 400 senior executives from biopharma, biotech, clinical research, and healthcare investment.
The Scrip Awards are more than a celebration — they represent a global stage for biopharma excellence, where innovation meets recognition, and where companies gain industry-wide credibility that can influence partnerships, investment, and talent acquisition.
MEDIA CONTACT
Ms. Natalia Farr
natalia.farr@pivotalcr.com